Lanxess (LXS) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
Warm welcome to shareholders, with a review of challenging macroeconomic and industry conditions in 2024, including recession and sector-specific headwinds.
Annual Stockholders' Meeting held on May 22, 2025, marking 20 years of operations.
Financial performance review
Operating result increased despite a 5% drop in sales; EBITDA pre-exceptionals rose 20% to EUR 614 million, at the upper end of forecasts.
Cost savings exceeded targets, with over EUR 110 million saved by end of 2023 and permanent reductions of EUR 150 million; further EUR 40 million in cost reductions targeted by end of 2025.
Net financial debt reduced by 5% to EUR 2.4 billion; free cash flow increased by EUR 188 million.
First quarter of 2025 showed a 32% earnings increase; full-year 2025 EBITDA pre-exceptionals forecasted at EUR 600–650 million amid increased macroeconomic uncertainty.
Dividend announcements
Stable dividend of EUR 0.10 per share proposed for 2024, totaling EUR 8.6 million in payouts, emphasizing cost discipline and debt reduction.
Dividend proposal submitted for shareholder approval at the meeting.
Latest events from Lanxess
- Q2 2026 saw strong sales and EBITDA growth, positive cash flow, and guidance reaffirmed.LXS
Q2 2026 (Media) - Q2 2026 delivered higher sales, strong EBITDA, and positive cash flow, but net income stayed negative.LXS
Q2 2026 - Sales and earnings fell, but debt reduction, restructuring, and sustainability drive resilience.LXS
AGM 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained amid persistent market headwinds.LXS
Q1 2026 (Media) - Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 2026 - Sales and EBITDA fell, debt reduced, and EUR 100M cost savings with 550 job cuts announced.LXS
Q4 2025 (Media) - 2026 EBITDA guidance is €450–550 million, with recovery expected in H2 2026.LXS
Q4 2025 - Sales and EBITDA fell sharply in Q3 2025, with cost actions and divestments improving leverage.LXS
Q3 2025 - EBITDA pre rose 32% to €133m, guidance held, and Urethane sale proceeds to reduce debt.LXS
Q1 2025